SOX2 and neoplasm: Downregulating ACSVL3 decreased the expression of markers and regulators associated with stem cell self‐renewal, including CD133, Musashi‐1, SOX2, and aldehyde dehydrogenase, suggesting that ACSVL3 participates in the maintenance of GSCs and affects the tumor‐initiating capacity of GSCs.100